NCT01436357: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT01436357 |
|---|---|
| Title | A Staged Phase I/II Study, to Assess Safety, Efficacy and Immunogenicity of a New Hepatitis C Prophylactic Vaccine Based on Sequential Use of AdCh3NSmut1 and MVA-NSmut |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | March 6, 2012 |
| Completion date | May 25, 2018 |
| Required reporting date | May 25, 2019, midnight |
| Actual reporting date | May 24, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |